Background: Community pharmacies serve as accessible points of care, offering essential services such as medication dispensing, health consultations, vaccinations, and chronic disease management, thereby playing a critical role in the healthcare system. This study aims to identify and evaluate the factors that obstruct general public-pharmacist interactions, providing insights to enhance pharmacy environments.
Methods: A total of 406 general publics were surveyed using a validated questionnaire. Statistical analysis was performed with categorical variables presented as frequencies and percentages, and continuous variables as medians with 95% confidence intervals. Binary regression models were used to explore the relationships between sociodemographic characteristics and communication barriers, with a significance level set at < 0.05 for all analyses.
Results: The primary reasons for pharmacy visits were collecting prescription medications (61.58%) and purchasing OTC products (55.17%), while health screenings were less common (9.11%). Barriers to effective communication included crowded environments (61.58%), limited counseling time (45.81%), and lack of privacy (45.07%). Binary logistic regression revealed that participants who visited the pharmacy weekly were 5.5 times more likely to experience high environmental barriers (OR: 5.502, = 0.002), while interacting with younger pharmacists increased the likelihood of personal barriers (OR: 12.357, = 0.025). Pharmacy proximity (75.12%) and shorter waiting times (47.29%) were the most influential factors in pharmacy preference, while additional services had minimal impact (20.2%).
Conclusion: Effective communication is crucial in community pharmacies for high-quality healthcare. This study identifies key barriers in the UAE and offers insights into targeted interventions to improve communication and public satisfaction.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11827033 | PMC |
| http://dx.doi.org/10.1080/20523211.2025.2460744 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Community pharmacy services in the late COVID-19 period: What has driven change?
Res Social Adm Pharm
March 2025
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute), Stubenring 6, 1010, Vienna, Austria; Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK. Electronic address:
Background: Community pharmacy appears to have undergone considerable change over the years.
Objectives: The objective of this research is to study the range of community pharmacy services provided in late stages of the COVID-19 pandemic and during the last decades and to identify potential drivers for change.
Methods: Four European countries (Austria, England, Estonia, and Portugal), which represent a balance in terms of income, organization of the health system and pharmacy services, were selected as case studies.
Identification of Issues Related to Enteral Nutrients Using a Database of Near-miss Events from Community Pharmacies.
Keio J Med
March 2025
Division of Social Pharmacy, Center for Social Pharmacy and Pharmaceutical Care Sciences, Faculty of Pharmacy, Keio University, Tokyo, Japan.
Undernutrition is a common risk after surgery or during periods when oral dietary intake is challenging. Enteral nutrients, frequently utilized in nutritional management, are drugs associated with multiple contraindications involving pathology and allergy, and they require careful attention in dispensing. However, the occurrence of nutrition-related incidents in community pharmacies remains unknown.
View Article and Find Full Text PDFDiscount pharmacies may save patients significant money on androgenetic alopecia medications compared to both traditional pharmacies and direct-to-consumer companies.
J Am Acad Dermatol
March 2025
Department of Dermatology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA. Electronic address:
Comparison of antibiotic provision associated with acute sore throat symptom management in community pharmacies in Wales and England: a natural policy experiment.
J Antimicrob Chemother
March 2025
Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Background: Acute sore throat is managed in community pharmacies in England and Wales under different clinical pathways: Acute Sore Throat Pharmacy First (ASTPF) and Sore Throat Test and Treat (STTT), respectively. ASTPF launched in 2024 and allows antibiotic supply with FeverPAIN scores 4 and 5. STTT launched in 2018 and allows antibiotic supply with FeverPAIN ≥2 or Centor ≥3, if point-of-care testing confirms presence of group A Streptococcus (GAS).
View Article and Find Full Text PDFIdentifying Adverse Events in Outpatients With Prostate Cancer Using Pharmaceutical Care Records in Community Pharmacies: Application of Named Entity Recognition.
JMIR Cancer
March 2025
Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
Background: Androgen receptor axis-targeting reagents (ARATs) have become key drugs for patients with castration-resistant prostate cancer (CRPC). ARATs are taken long term in outpatient settings, and effective adverse event (AE) monitoring can help prolong treatment duration for patients with CRPC. Despite the importance of monitoring, few studies have identified which AEs can be captured and assessed in community pharmacies, where pharmacists in Japan dispense medications, provide counseling, and monitor potential AEs for outpatients prescribed ARATs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!